Literature DB >> 26330957

Factors Affecting Survival in Patients Undergoing Palliative Spine Surgery for Metastatic Lung and Hepatocellular Cancer: Dose the Type of Surgery Influence the Surgical Results for Metastatic Spine Disease?

Kee-Yong Ha1, Young Hoon Kim1, Ju-Hyun Ahn1, Hyung-Youl Park1.   

Abstract

BACKGROUND: Surgical treatment for metastatic spine disease has been becoming more prominent with the help of technological advances and a few favorable reports on the surgery. In cases of this peculiar condition, it is necessary to establish the role of surgery and analyze the factors affecting survival.
METHODS: From January 2011 to April 2015, 119 patients were surgically treated for metastatic spine lesions. To reduce the bias along the heterogeneous cancers, the primary cancer was confined to either the lung (n = 25) or the liver (n = 18). Forty-three patients (male, 32; female, 11; mean age, 57.5 years) who had undergone palliative surgery were enrolled in this study. Posterior decompression and fusion was performed in 30 patients (P group), and anteroposterior (AP) reconstruction was performed in 13 patients (AP group) for palliative surgery. Pre- and postoperative (3 months) pain (visual analogue scale, VAS), performance status (Karnofsky performance score), neurologic status (American Spinal Injury Association [ASIA] grade), and spinal instability neoplastic score (SINS) were compared. The survival period and related hazard factors were also assessed by Kaplan-Meier and Cox regression analysis.
RESULTS: Most patients experienced improvements in pain and performance status (12.3% ± 17.2%) at 3 months postoperatively. In terms of neurologic recovery, 9 patients (20.9%) graded ASIA D experienced neurological improvement to ASIA E while the remainder was status quo. In an analysis according to operation type, there was no significant difference in patient demographics. At 12 months postoperatively, cumulative survival rates were 31.5% and 38.7% for the P group and the AP group, respectively (p > 0.05). Survival was not affected by the pre- and postoperative pain scale, Tokuhashi score, neurologic status, SINS, or operation type. Preoperative Karnofsky performance score (hazard ratio, 0.93; 95% confidence interval [CI], 0.89 to 0.96) and improvement of performance status after surgery (hazard ratio, 0.95; 95% CI, 0.92 to 0.97) significantly affected survival after operation.
CONCLUSIONS: There was no significant difference in surgical outcomes and survival rates between posterior and AP surgery for metastatic lesions resulting from lung and hepatocellular cancer. Preoperative Karnofsky score and improvement of performance status had a significant impact on the survival rate following surgical treatment for these metastatic spine lesions.

Entities:  

Keywords:  Neoplasm metastasis; Prognosis; Spine

Mesh:

Year:  2015        PMID: 26330957      PMCID: PMC4553283          DOI: 10.4055/cios.2015.7.3.344

Source DB:  PubMed          Journal:  Clin Orthop Surg        ISSN: 2005-291X


  17 in total

1.  Predictive value of Tokuhashi and Tomita scores in patients with metastatic spine disease.

Authors:  Sotiris Papastefanou; Kalliopi Alpantaki; Gabriel Akra; Pavlos Katonis
Journal:  Acta Orthop Traumatol Turc       Date:  2012       Impact factor: 1.511

2.  Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.

Authors:  Roy A Patchell; Phillip A Tibbs; William F Regine; Richard Payne; Stephen Saris; Richard J Kryscio; Mohammed Mohiuddin; Byron Young
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis.

Authors:  Yasuaki Tokuhashi; Hiromi Matsuzaki; Hiroshi Oda; Masashi Oshima; Junnosuke Ryu
Journal:  Spine (Phila Pa 1976)       Date:  2005-10-01       Impact factor: 3.468

Review 4.  A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression.

Authors:  D Andrew Loblaw; Gunita Mitera; Michael Ford; Normand J Laperriere
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-13       Impact factor: 7.038

5.  Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group.

Authors:  Daryl R Fourney; Evan M Frangou; Timothy C Ryken; Christian P Dipaola; Christopher I Shaffrey; Sigurd H Berven; Mark H Bilsky; James S Harrop; Michael G Fehlings; Stefano Boriani; Dean Chou; Meic H Schmidt; David W Polly; Roberto Biagini; Shane Burch; Mark B Dekutoski; Aruna Ganju; Peter C Gerszten; Ziya L Gokaslan; Michael W Groff; Norbert J Liebsch; Ehud Mendel; Scott H Okuno; Shreyaskumar Patel; Laurence D Rhines; Peter S Rose; Daniel M Sciubba; Narayan Sundaresan; Katsuro Tomita; Peter P Varga; Luiz R Vialle; Frank D Vrionis; Yoshiya Yamada; Charles G Fisher
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

6.  Surgery improves pain, function and quality of life in patients with spinal metastases: a prospective study on 118 patients.

Authors:  Gerald M Y Quan; Jean-Marc Vital; Nicholas Aurouer; Ibrahim Obeid; Jean Palussière; Abou Diallo; Vincent Pointillart
Journal:  Eur Spine J       Date:  2011-06-26       Impact factor: 3.134

Review 7.  Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group.

Authors:  D Andrew Loblaw; James Perry; Alexandra Chambers; Normand J Laperriere
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

8.  Surgical treatment of sacral metastases: indications and results.

Authors:  Iman Feiz-Erfan; Benjamin D Fox; Remi Nader; Dima Suki; Indro Chakrabarti; Ehud Mendel; Ziya L Gokaslan; Ganesh Rao; Laurence D Rhines
Journal:  J Neurosurg Spine       Date:  2012-08-17

9.  Modern techniques in the treatment of patients with metastatic spine disease.

Authors:  Han Jo Kim; Jacob M Buchowski; Charbel D Moussallem; Peter S Rose
Journal:  Instr Course Lect       Date:  2013

Review 10.  [Vertebral stability in management of spinal metastases. Criteria and strategies for operative interventions].

Authors:  B Wiedenhöfer; M Möhlenbruch; S Hemmer; B Lehner; K Klöckner; M Akbar
Journal:  Orthopade       Date:  2012-08       Impact factor: 1.087

View more
  3 in total

1.  Instrumented Spinal Stabilization without Fusion for Spinal Metastatic Disease.

Authors:  Dori Drakhshandeh; James A Miller; Andrew J Fabiano
Journal:  World Neurosurg       Date:  2017-12-21       Impact factor: 2.104

2.  Estimating survival and choosing treatment for spinal metastases: Do spine surgeons agree with each other?

Authors:  Quirina C B S Thio; Nuno Rui Paulino Pereira; Olivier van Wulfften Palthe; Daniel M Sciubba; Jos A M Bramer; Joseph H Schwab
Journal:  J Orthop       Date:  2021-11-27

3.  Prognosis of Single Spinal Metastatic Tumors: Predictive Value of the Spinal Instability Neoplastic Score System for Spinal Adverse Events.

Authors:  Sam Yeol Chang; Jae Hong Ha; Sang Gyo Seo; Bong-Soon Chang; Choon-Ki Lee; Hyoungmin Kim
Journal:  Asian Spine J       Date:  2018-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.